These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34593607)

  • 21. Hypoxia and metastasis in an orthotopic cervix cancer xenograft model.
    Chaudary N; Mujcic H; Wouters BG; Hill RP
    Radiother Oncol; 2013 Sep; 108(3):506-10. PubMed ID: 23856487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.
    Jansen JF; Schöder H; Lee NY; Wang Y; Pfister DG; Fury MG; Stambuk HE; Humm JL; Koutcher JA; Shukla-Dave A
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1403-10. PubMed ID: 19906496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review).
    Onishi H; Nakamura K; Yanai K; Nagai S; Nakayama K; Oyama Y; Fujimura A; Ozono K; Yamasaki A
    Oncol Rep; 2022 May; 47(5):. PubMed ID: 35315500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of [
    Jiang H; Zhang R; Jiang H; Zhang M; Guo W; Feng G; Pan W; Xu H; Wang S
    Nucl Med Biol; 2019; 72-73():36-44. PubMed ID: 31330410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric Imaging of Tumor Hypoxia and Perfusion with
    Grkovski M; Schöder H; Lee NY; Carlin SD; Beattie BJ; Riaz N; Leeman JE; O'Donoghue JA; Humm JL
    J Nucl Med; 2017 Jul; 58(7):1072-1080. PubMed ID: 28183993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative Analysis of [
    Shi K; Bayer C; Astner ST; Gaertner FC; Vaupel P; Schwaiger M; Huang SC; Ziegler SI
    Mol Imaging Biol; 2017 Feb; 19(1):120-129. PubMed ID: 27379986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
    Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
    Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):261-270. PubMed ID: 28734696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (18)F-fluoromisonidazole PET reveals spatial and temporal heterogeneity of hypoxia in mouse models of human non-small-cell lung cancer.
    Cui YL; Wang X; Li XF
    Future Oncol; 2015; 11(20):2841-9. PubMed ID: 26361064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma.
    Mapelli P; Picchio M
    Int J Biol Markers; 2020 Feb; 35(1_suppl):42-46. PubMed ID: 32079461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation.
    Wong H; Alicke B; West KA; Pacheco P; La H; Januario T; Yauch RL; de Sauvage FJ; Gould SE
    Clin Cancer Res; 2011 Jul; 17(14):4682-92. PubMed ID: 21610148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. M2 macrophage-derived IL6 mediates resistance of breast cancer cells to hedgehog inhibition.
    Xu X; Ye J; Huang C; Yan Y; Li J
    Toxicol Appl Pharmacol; 2019 Feb; 364():77-82. PubMed ID: 30578886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulforaphene Interferes with Human Breast Cancer Cell Migration and Invasion through Inhibition of Hedgehog Signaling.
    Bao C; Kim MC; Chen J; Song J; Ko HW; Lee HJ
    J Agric Food Chem; 2016 Jul; 64(27):5515-24. PubMed ID: 27327035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells.
    Kim H; Lin Q; Glazer PM; Yun Z
    Breast Cancer Res; 2018 Mar; 20(1):16. PubMed ID: 29510720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
    Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S
    Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxic volume evaluated by
    Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Shiga T; Satoh A; Tamaki N
    Int J Oral Maxillofac Surg; 2018 May; 47(5):553-560. PubMed ID: 29030021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to Smoothened-targeting Hedgehog inhibition.
    Das S; Samant RS; Shevde LA
    J Biol Chem; 2013 Apr; 288(17):11824-33. PubMed ID: 23508962
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Reeves KM; Song PN; Angermeier A; Della Manna D; Li Y; Wang J; Yang ES; Sorace AG; Larimer BM
    Clin Cancer Res; 2022 Jan; 28(2):327-337. PubMed ID: 34615724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.
    Meerang M; Bérard K; Felley-Bosco E; Lauk O; Vrugt B; Boss A; Kenkel D; Broggini-Tenzer A; Stahel RA; Arni S; Weder W; Opitz I
    Mol Cancer Ther; 2016 May; 15(5):1095-105. PubMed ID: 26839306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET.
    Bejot R; Kersemans V; Kelly C; Carroll L; King RC; Gouverneur V; Elizarov AM; Ball C; Zhang J; Miraghaie R; Kolb HC; Smart S; Hill S
    Nucl Med Biol; 2010 Jul; 37(5):565-75. PubMed ID: 20610161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.